Mela Sciences' FDA struggle unveiled; Nanotubes for brain blood vessel imaging;

@FierceMedDev: ICYMI yesterday: Imaging pen may detect skin cancer faster. Article | Follow @FierceMedDev

@StacyALawrence: Med tech M&A gets much, much bigger during the first half. Special report | Follow @StacyALawrence

@VarunSaxena2: ICYMI last week: UPDATED with information from interview of CEO: NeuroPace RNS Stimulator secures add-on payments from CMS. Story | Follow @VarunSaxena2

@EmilyWFierce: Scientists created a 3-D, doughnut-shaped model of the human brain that can imitate neurological function. More from the NYT | Follow @EmilyWFierce

> Dr. Joseph Gulfo, former CEO of Mela Sciences, talks about the battle to get FDA approval for MelaFind in his new book. Review

> Researchers are exploring the use of fluorescence-based brain imaging without requiring craniotomy as an alternative to current, less efficient imaging methods. Study

> Population health and work flow technology company Acupera completed a $4 million financing led by Lightspeed Venture Partners. The funding will be used to scale the company's product development team. Release

Biotech News

@FierceBiotech: ICYMI yesterday: J&J's diabetes combo wins FDA nod in a fast-crowding space. Article | Follow @FierceBiotech

@DamianFierce: Digging into the FDA's priority review voucher. Who's willing to pay big for one? Report | Follow @DamianFierce

@EmilyMFierce: Gene editing method kills cervical cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce

> Tokai pitches a $75M IPO to fund its three-in-one cancer drug. News

> Intercept leaps again as deeper NASH data quiet some fears. Story

> UniQure bets on a gene therapy for heart failure. Article

Pharma News

@FiercePharma: Tops on FP Monday: Former top Sanofi exec Whitaker nabbed by Synta to shuttle cancer drug to market. Article | Follow @FiercePharma

@EricPFierce: Boehringer Ingelheim cutting jobs in Germany in 15% cost reduction move. Article|  Follow @EricPFierce

@CarlyHFierce: Generic Viagra Delivers Hidden Billionaire Duo in Brazil. Bloomberg story | Follow @CarlyHFierce

> Valeant's No. 3 shareholder: We don't need Allergan. Story

> Syria broadens corruption accusations against GlaxoSmithKline. Report

Biotech Research News

> 3-D bioengineered brain tissue grown in lab. Report

> Small molecule inhibitor reverses cognitive deficits of Alzheimer's in mice. More

> Glaxo: Ebola vaccine could be ready by 2015. Item

> Malaria vaccine alternative shows high protection in mice. Article

> Gene editing method kills cervical cancer cells. Story

Pharma Manufacturing News

> Baxter to add recombinant protein processing suite at Singapore plant. More

> Recalls overseen by FDA soar in 2013, 2014. Item

> Report: Immigrants make up 26% of U.S. drug production and distribution workforce. Story

> Pakistan indicts 76 customs officers in fake drug probe. News

> U.S. health emergency facilities ready to produce Ebola drugs. Article

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.